Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,510 | 289 | 95.1% |
| Consulting Fee | $150.00 | 1 | 2.6% |
| Education | $136.65 | 4 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,694 | 166 | $0 (2024) |
| ABBVIE INC. | $789.44 | 33 | $0 (2024) |
| Allergan Inc. | $352.42 | 11 | $0 (2018) |
| Boston Scientific Corporation | $343.99 | 7 | $0 (2024) |
| Celgene Corporation | $294.45 | 19 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $275.80 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $200.86 | 9 | $0 (2024) |
| COMSORT, Inc | $150.00 | 1 | $0 (2017) |
| Concordia Pharmaceuticals Inc. | $132.67 | 8 | $0 (2018) |
| CapsoVision, Inc. | $110.60 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $890.90 | 37 | Janssen Biotech, Inc. ($405.83) |
| 2023 | $878.16 | 43 | Janssen Biotech, Inc. ($418.19) |
| 2022 | $964.52 | 46 | Janssen Biotech, Inc. ($444.12) |
| 2021 | $650.90 | 41 | Janssen Biotech, Inc. ($477.32) |
| 2020 | $788.58 | 38 | Janssen Biotech, Inc. ($616.70) |
| 2019 | $441.30 | 38 | Janssen Biotech, Inc. ($235.23) |
| 2018 | $474.88 | 26 | AbbVie, Inc. ($148.92) |
| 2017 | $707.61 | 25 | Allergan Inc. ($332.84) |
All Payment Transactions
294 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: Immunology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $34.68 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $19.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $27.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: IMMUNOLOGY | ||||||
| 08/16/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $23.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Immunology | ||||||
| 07/30/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Immunology | ||||||
| 07/24/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Immunology | ||||||
| 07/10/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $89.23 | General |
| Category: EXALT Model D_ENDO | ||||||
| 07/09/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $26.69 | General |
| Category: GI | ||||||
| 06/25/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Neuroscience | ||||||
| 06/04/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Immunology | ||||||
| 05/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 901 | 987 | $648,913 | $99,298 |
| 2022 | 19 | 841 | 905 | $624,676 | $94,392 |
| 2021 | 16 | 844 | 918 | $580,866 | $93,322 |
| 2020 | 18 | 789 | 860 | $545,721 | $85,906 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 146 | 146 | $217,459 | $19,335 | 8.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 98 | 161 | $26,565 | $9,937 | 37.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 134 | 138 | $139,955 | $9,388 | 6.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 83 | 86 | $25,972 | $8,755 | 33.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 47 | 47 | $20,720 | $8,367 | 40.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 38 | 38 | $64,828 | $7,544 | 11.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 48 | $21,120 | $6,515 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 60 | $13,343 | $5,654 | 42.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $11,543 | $5,111 | 44.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 41 | 41 | $23,098 | $4,773 | 20.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 44 | $10,340 | $4,098 | 39.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $26,809 | $2,565 | 9.6% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $12,835 | $2,321 | 18.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $25,677 | $2,237 | 8.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 17 | $3,740 | $1,104 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $2,615 | $818.69 | 31.3% |
| 74360 | Review by radiologist of image to guide opening of digestive tract | Facility | 2023 | 36 | 37 | $2,294 | $773.67 | 33.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 133 | 134 | $200,580 | $17,854 | 8.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 53 | 53 | $23,138 | $9,460 | 40.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 81 | 81 | $24,462 | $8,624 | 35.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 109 | 113 | $116,260 | $8,352 | 7.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 80 | 124 | $20,460 | $6,961 | 34.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 44 | 44 | $19,360 | $6,868 | 35.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 32 | 33 | $56,154 | $6,659 | 11.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 39 | 41 | $22,784 | $4,992 | 21.9% |
About Robert Hower
Robert Hower is a Gastroenterology healthcare provider based in Erie, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053407155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Hower has received a total of $5,797 in payments from pharmaceutical and medical device companies, with $890.90 received in 2024. These payments were reported across 294 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,510).
As a Medicare-enrolled provider, Hower has provided services to 3,375 Medicare beneficiaries, totaling 3,670 services with total Medicare billing of $372,918. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Erie, PA
- Active Since 10/05/2006
- Last Updated 03/25/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1053407155
Products in Payments
- STELARA (Biological) $1,943
- REMICADE (Biological) $609.51
- ZEPOSIA (Drug) $294.45
- Linzess (Drug) $275.80
- RINVOQ (Biological) $217.45
- LINZESS (Drug) $193.01
- Humira (Biological) $188.07
- ENTYVIO (Biological) $187.28
- VIBERZI (Drug) $159.41
- General - Biliary Devices (Device) $157.81
- Donnatal (Drug) $132.67
- HUMIRA (Biological) $127.88
- TREMFYA (Drug) $125.87
- SKYRIZI (Biological) $113.23
- CapsoCam Plus (Device) $110.60
- Mavyret (Drug) $99.15
- EXALT Model D (Device) $89.23
- ZYMFENTRA (Biological) $69.65
- Amitiza (Drug) $65.55
- CLENPIQ (Drug) $59.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Erie
Brian Viviano, Do, DO
Gastroenterology — Payments: $41,498
William Wismer, Do, DO
Gastroenterology — Payments: $12,949
Dr. Vincent Fierro, D.o, D.O
Gastroenterology — Payments: $6,012
Mrs. Vladislava Buntic, M.d, M.D
Gastroenterology — Payments: $5,783
Dr. Brian Ng, Md, MD
Gastroenterology — Payments: $5,626
Segun Abogunde, Md, MD
Gastroenterology — Payments: $4,268